Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

The Pharmaceutical Market: Oman

254 visualizaciones

Publicado el

Espicom market intelligence, brought to you by Business Monitor InternationalOman Pharmaceuticals & Healthcare ReportOman's commendable public healthcare system and high-class tertiary and quaternary care hospitals will increase the uptake of medical tourism by GCC citizens. The Omani pharmaceutical market will continue to remain heavily reliant on imports due to the costly need to source raw ingredients for local manufacturing and lack of R&D backing. However, despite t he strict drug pricing system, we are likely to see more multinational companies penetrating the market and expanding volume sales, by addressing the increasing burden of non-communicable diseases in the country.Headline Expenditure Projections Pharmaceuticals : OMR151mn (US$391mn) in 2011 to OMR166mn in 2012; +9.9% in local currency terms and +11.3% in US dollar terms. Forecast revised upwards due to modi fications to historical figures. Healthcare: OMR742mn (US$1.93bn) in 2011 to OMR839mn (US$2.21bn) in 2012; +13.1% in local currency terms and +14.6% in US dollar terms. Forecast revised upwards due to modifications to historical figures . Medical devices: OMR40mn (US$105mn) in 2011 to OMR44mn (US$116mn) in 2012; +9.5% in local currency terms and +10.9% in US dollar terms. Forecast revised upwards due to modi fications to historical figures. Risk / Reward Rating: Risk-Reward Rating scores represent a country's pharmaceutical market attractiveness for investment, which includes weightings of risk and rewards analysis of the wider macroeconomic environment. Oman's consistent score of 50.2 out of 100 over the past three quarters places it above the MEA regional average of 44.2, indicating a favourable and stable environment for multinational investment. Oman also currently maintains its position as ninth out of 30 countries in the MEA matrix.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

  • Inicia sesión para ver los comentarios

  • Sé el primero en recomendar esto

The Pharmaceutical Market: Oman

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The Pharmaceutical Market: OmanPublished on January 2013 Report SummaryEspicom market intelligence, brought to you by Business Monitor InternationalOman Pharmaceuticals & Healthcare ReportOmans commendable public healthcare system and high-class tertiary and quaternary care hospitals will increase the uptake ofmedical tourism by GCC citizens. The Omani pharmaceutical market will continue to remain heavily reliant on imports due to thecostly need to source raw ingredients for local manufacturing and lack of R&D backing. However, despite t he strict drug pricingsystem, we are likely to see more multinational companies penetrating the market and expanding volume sales, by addressing theincreasing burden of non-communicable diseases in the country.Headline Expenditure ProjectionsPharmaceuticals : OMR151mn (US$391mn) in 2011 to OMR166mn in 2012; +9.9% in local currency terms and +11.3% in US dollarterms. Forecast revised upwards due to modi fications to historical figures.Healthcare: OMR742mn (US$1.93bn) in 2011 to OMR839mn (US$2.21bn) in 2012; +13.1% in local currency terms and +14.6% inUS dollar terms. Forecast revised upwards due to modifications to historical figures .Medical devices: OMR40mn (US$105mn) in 2011 to OMR44mn (US$116mn) in 2012; +9.5% in local currency terms and +10.9% inUS dollar terms. Forecast revised upwards due to modi fications to historical figures.Risk / Reward Rating: Risk-Reward Rating scores represent a countrys pharmaceutical market attractiveness for investment, whichincludes weightings of risk and rewards analysis of the wider macroeconomic environment. Omans consistent score of 50.2 out of100 over the past three quarters places it above the MEA regional average of 44.2, indicating a favourable and stable environment formultinational investment. Oman also currently maintains its position as ninth out of 30 countries in the MEA matrix.Competitive LandscapeThe competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors. Table of ContentTable of ContentsExecutive Summary 5SWOT Analysis 7The Pharmaceutical Market: Oman (From Slideshare) Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Oman Pharmaceuticals And Healthcare Industry SWOT 7Oman Political SWOT 8Oman Economic SWOT 8Oman Business Environment SWOT 9Pharmaceutical Risk/Reward Ratings 10Table: Middle East And Africa (MEA) Pharmaceutical Risk/Reward Ratings, Q113 10Rewards 12Risks 13Oman Market Summary 15Regulatory Regime 17Regulatory Developments 18Intellectual Property Regime 18Table: IP Laws In Oman 19Regional Harmonisation 19Pricing And Reimbursement Regime 20Recent Pricing And Reimbursement Developments 21Free Trade Agreements 22Industry Developments 24Epidemiology 24Communicable Diseases 25Non-Communicable Diseases 26Public Health Developments 27Healthcare Sector 28Table: Number Of Health Centres In Oman By Region 28Table: Number And Type Of Health Institutions In Oman 29Healthcare System Developments 29Table: Healthcare Reform Targets 31Private Healthcare Sector 31Private Healthcare Developments 32Healthcare Funding 33Healthcare Insurance 33Telemedicine 34Medical Tourism 34Research And Biotechnology 36Clinical Trials 37Medical Devices 38Industry Forecast Scenario 39Overall Market Forecast 39Table: Oman Pharmaceutical Sales, Historical Data And Forecasts, 2007-2017 40Key Growth Factors Industry 41Table: Oman Healthcare Expenditure Trends, Historical Data and Forecasts 42Table: Oman Government Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 42Table: Oman Private Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 43Key Growth Factors Macroeconomic 44Table: Oman GDP By Expenditure, Current Prices Breakdown, 2008-2016 48Prescription Drug Market Forecast 49Table: Oman Prescription Drug Market Indicators, Historical Data And Forecasts, 2009-2017 50Patented Drug Market Forecast 51The Pharmaceutical Market: Oman (From Slideshare) Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Table: Oman Patented Drug Market Indicators, Historical Data and Forecasts 52Generic Drug Market Forecast 53Table: Oman Generics Drug Market Indicators, Historical Data And Forecasts, 2009-2017 54OTC Medicine Market Forecast 55Table: Oman Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 56Pharmaceutical Trade Forecast 57Table: Oman Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017 58Table: Oman Pharmaceutical Trade Data And Forecasts (OMRmn), 2009-2017 58Medical Device Market Forecast 59Table: Oman Medical Device Market Indicators, Historical Data and Forecasts, 2009-2017 60Other Healthcare Data Forecasts 61Key Risks To BMIs Forecasts 62Competitive Landscape 63Pharmaceutical Sector 63Domestic Industry 63Foreign Industry 64Pharmaceutical Distribution 65Company Profiles 66Local Companies 66Zynova/Oman Pharmaceutical Products Company (OPPC) 66National Pharmaceutical Industries (NPI) 68Multinational Companies 70Novartis 70GlaxoSmithKline 72Sanofi 73Johnson & Johnson 74Demographic Outlook 75Table: Population By Age Group, 1990-2020 (000) 76Table: Population By Age Group, 1990-2020 (% of total) 76Table: Key Population Ratios, 1990-2020 77Table: Rural/Urban Population Split, 1990-2020 77Glossary 79BMI Methodology 81How We Generate Our Pharmaceutical Industry Forecasts 81Risk/Reward Ratings Methodology 82Ratings Overview 82Table: Pharmaceutical Business Environment Indicators 83Weighting 84Table: Weighting Of Components 84Sources 84The Pharmaceutical Market: Oman (From Slideshare) Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The Pharmaceutical Market: Oman Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 397.25 Quantity: _____ Site License--USD 2 794.50 Quantity: _____ Corporate License--USD 8 383.50 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The Pharmaceutical Market: Oman (From Slideshare) Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The Pharmaceutical Market: Oman (From Slideshare) Page 5/5

×